Rino Ragno
Istituto Pasteur - Fondazione Cenci Bolognetti
Dipartimento di Studi Farmaceutici
Università degli Studi di Roma La Sapienza
P.le A. Moro 5
Italy
Name/email consistency: high
- Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. Ragno, R., Simeoni, S., Rotili, D., Caroli, A., Botta, G., Brosch, G., Massa, S., Mai, A. Eur. J. Med. Chem (2008)
- 3-D QSAR studies on histone deacetylase inhibitors. A GOLPE/GRID approach on different series of compounds. Ragno, R., Simeoni, S., Valente, S., Massa, S., Mai, A. J. Chemical Information Modeling (2006)
- Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. Ragno, R., Coluccia, A., La Regina, G., De Martino, G., Piscitelli, F., Lavecchia, A., Novellino, E., Bergamini, A., Ciaprini, C., Sinistro, A., Maga, G., Crespan, E., Artico, M., Silvestri, R. J. Med. Chem. (2006)
- HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. Ragno, R., Frasca, S., Manetti, F., Brizzi, A., Massa, S. J. Med. Chem. (2005)